You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港交所(00388.HK):疫情對醫療板塊投融資需求有一定刺激作用
阿思達克 03-23 16:02
港交所(00388.HK)董事總經理、市場發展科副主管及環球上市服務部主管鮑海潔表受《新浪財經》訪問時表示,新型肺炎疫情對整個醫療板塊的投融資需求有一定刺激作用,未來有關板塊將持續快速發展,而疫情爆發後,全球醫療行業的需求正處於快速上升周期。

她表示,生物科技板塊上市新規在香港落實近兩年,不論從生物科技公司、投資者角度,收穫也不錯,甚至惠及香港整個醫療板塊,從集資額、交易量及市值都有很大提升。醫療板塊新股集資從2017年76億元,增至去年的395億元,期內日均交易量由16億增至37億元,市值由約8,550億升至超過1.56萬億元,新上市公司的市值貢獻已經達到17%。

鮑海潔又認為,香港資本市場在醫藥領域最大的優勢是紮根中國連接世界。香港市場的投資者非常多元化,既有海外投資者,也有大量中國投資者,這對於醫藥企業來說是很好的機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account